Skip to main content

Table 5 Hormonal levels of the study population

From: Comparative analysis of clinical symptoms and biochemical alterations in women with polycystic ovary syndrome: assessing the impact of type 1 diabetes versus non-diabetic controls

Hormone

Non-diabetic controls (No. = 50)

Diabetic patients (No. = 50)

% difference

t

P-value

T testosterone (ng/ml)

0.44 ± 0.11

0.58 ± 0.11

26.3

6.112

 < 0.001

  Range (min–max)

0.2–0.7

0.39–0.80

   

FSH (mlU/ml)

5.6 ± 1.9

6.6 ± 4.3

18.0

1.512

0.135

  Range (min–max)

2.1–12.7

0.1–18.7

   

LH (mlU/ml)

6.1 ± 2.9

6.9 ± 5.1

12.3

1.070

0.288

  Range (min–max)

0.7–13.7

0.3–25.1

   

Insulin (mlU/ml)

10.8 ± 4.5

15.8 ± 12.4

37.6

2.667

0.010

  Range (min–max)

4.9–24.8

2.2–59.2

   
  1. T testosterone total testosterone, FSH follicle stimulating hormone, LH luteinizing hormone, No. number; all values are presented as mean ± SD; P < 0.05: significant, P > 0.05: not significant